H.R. 6610, titled the 'Pharmacists Fight Back in Federal Employee Health Benefit Plans Act,' aims to regulate Pharmacy Benefit Managers (PBMs) that administer prescription drug benefits for federal employees. The bill seeks to limit the costs associated with PBMs by amending chapter 89 of title 5, United States Code. Key provisions include establishing specific reimbursement rates for pharmacies, prohibiting PBMs from engaging in anti-competitive practices such as steering patients to their own affiliated pharmacies, and imposing civil monetary penalties and potential debarment for non-compliance.
Supporters of H.R. 6610 argue that the bill will promote fair competition among pharmacies and ensure that federal employees have access to a wider range of pharmacy options. By setting clear reimbursement rates and prohibiting anti-competitive practices, the legislation is seen as a step toward reducing prescription drug costs and increasing transparency in the administration of federal employee health benefits.
Critics of the bill express concern that imposing strict regulations and penalties on PBMs could lead to increased administrative costs, which may ultimately be passed on to consumers. They also argue that limiting the operational flexibility of PBMs might reduce their ability to negotiate favorable drug prices, potentially leading to higher overall healthcare costs.
The analysis of H.R. 6610 reveals no direct industry overlaps between the sponsor Jake Auchincloss's top donor industries and the bill's subject matter, which focuses on pharmacists' roles in federal employee health benefit plans. The absence of overlapping interests suggests that the potential for conflicts of interest is minimal. The lobbying activity in this policy area, totaling over $500,000, comes from various sectors including agricultural retailers and transportation, none of which directly relate to the pharmaceutical industry or the specific concerns addressed in the bill. Voters should be aware that while there is significant lobbying activity, it does not appear to influence this particular legislation directly, reducing concerns about conflicts of interest.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| AGRICULTURAL RETAILERS ASSOCIATION | AGRICULTURAL RETAILERS ASSOCIATION | $210,000 |
| SOO LINE RAILROAD COMPANY | SOO LINE RAILROAD COMPANY | $130,500 |
| TS CONDUCTOR | FOX POTOMAC RESOURCES, LLC | $50,000 |
| PERMA-FIX ENVIRONMENTAL SERVICES | FOX POTOMAC RESOURCES, LLC | $50,000 |
| UNIVERSITY HEALTH SYSTEMS OF EASTERN CAROLINA, INC. D/B/A ECU HEALTH | UNIVERSITY HEALTH SYSTEMS OF EASTERN CAROLINA, INC. D/B/A ECU HEALTH | $41,075 |
| ISEMBARD LTD | HANBURY STRATEGY | $40,000 |
| BAY AREA COUNCIL | ORSO GROUP | $30,000 |
| CALIFORNIA FOREVER | ORSO GROUP | $30,000 |
| U.S. TRAVEL ASSOCIATION | AXADVOCACY GOVERNMENT RELATIONS | $30,000 |
| SHEPPARD PRATT HEALTH SYSTEM | MCALLISTER & QUINN, LLC | $30,000 |
| BEYOND IMPACT (ON BEHALF COMMUNITY JUSTICE ACTION FUND) | HANBURY STRATEGY | $20,000 |
| CAPITAL CORE GROUP, INC., ON BEHALF OF PARADISE IRRIGATION DISTRICT | LAW OFFICES OF GEORGE HARRIS, LLC | $10,000 |
| CITY OF JACKSON | LAW OFFICES OF GEORGE HARRIS, LLC | undisclosed |
| HOLTEC INTERNATIONAL | FOX POTOMAC RESOURCES, LLC | undisclosed |
| FUSRAP COALITION | FOX POTOMAC RESOURCES, LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
